CVS is seeking a customer for BSwift, the gains technological innovation small business it obtained eight decades in the past, sources tell Axios.
What is actually happening: A Goldman Sachs-run divestiture course of action is nicely into its 2nd round, resources say.
- Deal textbooks were distributed in early July, with bids submitted at minimum a handful of months back, 1 of the sources states.
- The method at first specific a broad variety of opportunity strategic and non-public equity customers, sources say.
By the numbers: BSwift is projecting about $230 million and $50 million of 2022 revenue and EBITDA, respectively, sources say.
- BSwift serves 65,000 employer teams, boasting that it drives 25% more cost-effective premiums amid customers and 98% consumer retention.
What they’re indicating: Expansion has been gradual sitting down under the umbrella of CVS-owned Aetna, but sources say BSwift is fantastic at what it does — delivering vital technology for employee gains browsing, enrollment and administration.
- “It is really even now a powerful asset” but, one supply states, “could use more TLC.”
Context: The prepared divestiture isn’t all that surprising contemplating how public CVS has been about its intentions to shift closer to the individual and treatment delivery. (Primary care, in distinct.)
💭 Our assumed bubble: Sources say the BSwift procedure begun out “quite broad,” which alerts to us that there is just not an obvious established of consumers for the asset.
- Strategics could obtain the firm and cross-provide BSwift’s technological innovation, or a sponsor may possibly see a more substantial opportunity to roll up other positive aspects software package belongings or double down on affected person engagement.
Condition of engage in: Businessolver, yet another options provider for gains administration and engagement, was obtained by Stone Stage Funds in December — maybe location the stage for CVS to place out feelers for renewed fascination in BSwift.
Flashback: In late 2014, Aetna purchased BSwift from Boston-based mostly PE company Good Hill Associates for around $400 million. (CVS then acquired Aetna in late 2018.)
- Great Hill had invested in BSwift only 7 months before — suggesting quick and sizable return for the PE organization targeting investments of $25 million to $150 million at that time (it has considering the fact that long gone up in size).
- It also suggests that Aetna was gung-ho on the technologies platform and presumably bought BSwift on direct approach.
The bottom line: Whoever purchases BSwift — and at what value — is not promptly very clear. Natural beauty is in the eye of the beholder. CVS and Goldman declined to comment.
More Stories
Leading 10 positive aspects of company method automation
Credit card debt ceiling politics could derail options for modernizing unemployment positive aspects supply
IEEE President’s Note: Connecting the Unconnected